Ceftolozane–tazobactam for the treatment of osteomyelitis caused by multidrug-resistant pathogens: a case series

Ceftolozane–tazobactam (CT) is a recently approved novel cephalosporin and β-lactamase inhibitor combination agent with in vitro activity against various Gram-positive and Gram-negative pathogens, including several multidrug-resistant (MDR) Gram-negative organisms. CT is currently approved by the US...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xing Tan, Ryan P. Moenster
Formato: article
Lenguaje:EN
Publicado: SAGE Publishing 2019
Materias:
Acceso en línea:https://doaj.org/article/982b73dfcb534ff0a6e19da8767df082
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!